An anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease [A174022]. Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent [A174019]. Throughout the late seventies and the eighties, important research initiatives developed stable mesalazine formulations like the eudragit-S coating of Asacol brand mesalazine and the Pentasa brand's encapsulation of mesalazine within microgranules [A174019]. In the present day, contemporary research regarding novel methods to stabilize mesalazine continues and interest in the agent's capacity to decrease inflammatory activity and subsequently potentially reduce the risk of colorectal cancer in conditions like ulcerative colitis is maintained.[A174019,A174022]
Synonyms
Mesalazinum
Mésalazine
m-Aminosalicylic acid
5-aminosalicylic acid
Mesalazine
Mesalazina
p-Aminosalicylsaeure
3-carboxy-4-hydroxyaniline
mesalazin
5-ASA
Mesalamine
Brand Names
Pentasa Extended-release Tablets 250mg
Asacol
Ntp-5-aminosalicylic Acid
Apriso
Lialda
Pentasa
Octasa
Salofalk (r) 5-asa Enteric Coated Tab- 250mg
Salofalk
Mezavant
Pendo-5 Asa
Mesalamine
Mesalamine Rectal
Teva-5 Asa
Asacol HD
Mezera
Salofalk (r) 5-asa Suppositories - 250mg
sfRowasa Sulfite-Free Formulation
sF Rowasa
Asacol Hd
Pentasa Enema 2g/100ml
Zaldyon
Rowasa
Canasa
Mesasal
Asacol 800
Delzicol
5-asa
Indication
Mesalazine is indicated for the treatment of mildly to moderately active ulcerative colitis in adults and patients 5 years or older.[L36280,L36275]. Mesalazine is also indicated for the maintenance of remission of ulcerative colitis in adults and maintenance of remission of Crohn's ileocolitis.[L44196,L5101]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682